Back to search

Article

The NKCC1 inhibitor bumetanide has no discernible effect on plasma cell survival, persistence or antibody secretion

2026-05-26

Abstract excerpt

Long-lived plasma cells (LLPC) sustain humoral immunity but also contribute to the persistence of pathogenic autoantibodies in autoimmune diseases. New therapies targeting LLPC are therefore desirable. Recent studies have shown increased expression of Slc12a2 , encoding the Na + -K + -Cl − cotransporter (NKCC1), in LLPC. This study investigated whether NKCC1 activity was required for plasma cell survival, pers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c31c49f8-c6fa-5a98-a39d-83532749f0fc
DOI
10.64898/2026.05.22.727109
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The NKCC1 inhibitor bumetanide has no discernible effect on plasma cell survival, persistence or antibody secretionDOI 10.64898/2026.05.22.727109
Select a neighboring publication to make it the new centre.